The rise and fall of Theranos, in one graphic
Advertisement
Theranos, the blood-testing startup with a $9 billion valuation, has had a turbulent year.
Advertisement
On Wednesday, the company announced major changes, including that its president and chief operating officer Sunny Balwani, who served as CEO and founder Elizabeth Holmes' second-in-command, is retiring.
Here's a review of the events that led up to this point over the last year.
Complimentary Tech Event
Transform talent with learning that works
Capability development is critical for businesses who want to push the envelope of innovation.Discover how business leaders are strategizing around building talent capabilities and empowering employee transformation.Know More
Dragan Radovanovic/Business Insider
Advertisement
- US buys 81 Soviet-era combat aircraft from Russia's ally costing on average less than $20,000 each, report says
- 2 states where home prices are falling because there are too many houses and not enough buyers
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- Foreign tourist arrivals in India will cross pre-pandemic level in 2024
- Upcoming smartphones launching in India in May 2024
- Markets rebound in early trade amid global rally, buying in ICICI Bank and Reliance
- Women in Leadership
- Rupee declines 5 paise to 83.43 against US dollar in early trade